{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T08:48:09Z","timestamp":1794559689241,"version":"4.9.1"},"reference-count":49,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.jid.2017.10.024","type":"journal-article","created":{"date-parts":[[2017,11,2]],"date-time":"2017-11-02T12:18:55Z","timestamp":1509625135000},"page":"760-767","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":106,"title":["Risk of Incident Liver Disease in Patients with Psoriasis, Psoriatic Arthritis, and Rheumatoid Arthritis: A Population-Based Study"],"prefix":"10.1016","volume":"138","author":[{"given":"Alexis","family":"Ogdie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sungat K.","family":"Grewal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8481-4711","authenticated-orcid":false,"given":"Megan H.","family":"Noe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel B.","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junko","family":"Takeshita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zelma C.","family":"Chiesa Fuxench","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rotonya M.","family":"Carr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel M.","family":"Gelfand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2017.10.024_bib1","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/ced.12672","article-title":"Patients with psoriasis are at a higher risk of developing nonalcoholic fatty liver disease","volume":"40","author":"Abedini","year":"2015","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jid.2017.10.024_bib2","first-page":"251","article-title":"Generalisability of The Health Improvement Network (THIN) database: demographics, chronic disease prevalence and mortality rates","volume":"19","author":"Blak","year":"2011","journal-title":"Inform Prim Care"},{"key":"10.1016\/j.jid.2017.10.024_bib3","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1751-0473-3-17","article-title":"Purposeful selection of variables in logistic regression","volume":"3","author":"Bursac","year":"2008","journal-title":"Source Code Biol Med"},{"key":"10.1016\/j.jid.2017.10.024_bib4","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.gtc.2016.07.003","article-title":"Nonalcoholic fatty liver disease: pathophysiology and management","volume":"45","author":"Carr","year":"2016","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.jid.2017.10.024_bib5","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1136\/bmj.300.6732.1092","article-title":"The Read clinical classification","volume":"300","author":"Chisholm","year":"1990","journal-title":"BMJ"},{"key":"10.1016\/j.jid.2017.10.024_bib6","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.semarthrit.2016.05.012","article-title":"Psoriasis, psoriatic arthritis, and rheumatoid arthritis: Is all inflammation the same?","volume":"46","author":"Coates","year":"2016","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.jid.2017.10.024_bib7","doi-asserted-by":"crossref","first-page":"R270","DOI":"10.1186\/ar4118","article-title":"Suboptimal cardiovascular risk factor identification and management in patients with rheumatoid arthritis: a cohort analysis","volume":"14","author":"Desai","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jid.2017.10.024_bib8","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1001\/jamacardio.2017.1213","article-title":"Association between skin and aortic vascular inflammation in patients with psoriasis: a case\u2013cohort study using positron emission tomography\/computed tomography","volume":"2","author":"Dey","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jid.2017.10.024_bib9","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1093\/rheumatology\/ket343","article-title":"The independent impact of psoriatic arthritis and rheumatoid arthritis on diabetes incidence: a UK population-based cohort study","volume":"53","author":"Dubreuil","year":"2014","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jid.2017.10.024_bib10","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1046\/j.1365-2125.1998.00701.x","article-title":"Use of the UK General Practice Research Database for pharmacoepidemiology","volume":"45","author":"Garcia Rodriguez","year":"1998","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jid.2017.10.024_bib11","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/jdv.13456","article-title":"Non-alcoholic fatty liver disease fibrosis score in patients with psoriasis","volume":"30","author":"Gisondi","year":"2016","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jid.2017.10.024_bib12","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.jhep.2009.04.020","article-title":"Non-alcoholic fatty liver disease in patients with chronic plaque psoriasis","volume":"51","author":"Gisondi","year":"2009","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jid.2017.10.024_bib13","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1136\/ard.2008.089441","article-title":"Development and initial validation of a screening questionnaire for psoriatic arthritis: the Toronto Psoriatic Arthritis Screen (ToPAS)","volume":"68","author":"Gladman","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jid.2017.10.024_bib14","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1002\/pds.2191","article-title":"Temporal and within practice variability in the health improvement network","volume":"20","author":"Haynes","year":"2011","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jid.2017.10.024_bib15","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1136\/annrheumdis-2016-210629","article-title":"Quantifying the hepatotoxic risk of alcohol consumption in patients with rheumatoid arthritis taking methotrexate","volume":"76","author":"Humphreys","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jid.2017.10.024_bib16","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.jaad.2008.11.906","article-title":"Methotrexate and psoriasis: 2009 National Psoriasis Foundation Consensus Conference","volume":"60","author":"Kalb","year":"2009","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jid.2017.10.024_bib17","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/pds.1335","article-title":"Validation studies of the health improvement network (THIN) database for pharmacoepidemiology research","volume":"16","author":"Lewis","year":"2007","journal-title":"Pharmacoepidemiology Drug Saf"},{"key":"10.1016\/j.jid.2017.10.024_bib18","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/pds.1784","article-title":"Validity of The Health Improvement Network (THIN) for epidemiologic studies of hepatitis C virus infection","volume":"18","author":"Lo Re","year":"2009","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jid.2017.10.024_bib19","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1210\/jc.2015-3444","article-title":"Body mass index and risk of nonalcoholic fatty liver disease: two electronic health record prospective studies","volume":"101","author":"Loomis","year":"2016","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jid.2017.10.024_bib20","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1440-0960.2012.00905.x","article-title":"The increased prevalence of non-alcoholic fatty liver disease in psoriatic patients: a study from South India","volume":"53","author":"Madanagobalane","year":"2012","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.jid.2017.10.024_bib21","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3390\/ijms17020217","article-title":"Relationship between non-alcoholic fatty liver disease and psoriasis: a novel hepato-dermal axis?","volume":"17","author":"Mantovani","year":"2016","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jid.2017.10.024_bib22","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/bjd.12941","article-title":"Methotrexate and liver fibrosis in people with psoriasis: a systematic review of observational studies","volume":"171","author":"Maybury","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2017.10.024_bib23","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.jhep.2009.06.008","article-title":"Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis","volume":"51","author":"Miele","year":"2009","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jid.2017.10.024_bib24","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1111\/jdv.14310","article-title":"Increased prevalence of HCV and hepatic decompensation in adults with psoriasis: a population-based study in the United Kingdom","volume":"31","author":"Noe","year":"2017","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jid.2017.10.024_bib25","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/pds.3677","article-title":"Validity of psoriatic arthritis and capture of disease modifying antirheumatic drugs in the health improvement network","volume":"23","author":"Ogdie","year":"2014","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jid.2017.10.024_bib26","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1136\/annrheumdis-2012-202424","article-title":"Risk of mortality in patients with psoriatic arthritis, rheumatoid arthritis and psoriasis: a longitudinal cohort study","volume":"73","author":"Ogdie","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jid.2017.10.024_bib27","article-title":"Risk of venous thromboembolism in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a general population-based cohort study","author":"Ogdie","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jid.2017.10.024_bib28","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1093\/rheumatology\/kew502","article-title":"Cause-specific mortality in patients with psoriatic arthritis and rheumatoid arthritis","volume":"56","author":"Ogdie","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jid.2017.10.024_bib29","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/BOR.0000000000000152","article-title":"Recognizing and managing comorbidities in psoriatic arthritis","volume":"27","author":"Ogdie","year":"2015","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.jid.2017.10.024_bib30","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1136\/annrheumdis-2014-205675","article-title":"Risk of major cardiovascular events in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a population-based cohort study","volume":"74","author":"Ogdie","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jid.2017.10.024_bib32","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.jhep.2013.09.027","article-title":"1 and 5 year survival estimates for people with cirrhosis of the liver in England, 1998\u20132009: a large population study","volume":"60","author":"Ratib","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jid.2017.10.024_bib33","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1038\/ajg.2015.191","article-title":"Causes of death in people with liver cirrhosis in England compared with the general population: a\u00a0population-based cohort study","volume":"110","author":"Ratib","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jid.2017.10.024_bib34","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/ajg.2013.405","article-title":"Diagnosis of liver cirrhosis in England, a cohort study, 1998\u20132009: a comparison with cancer","volume":"109","author":"Ratib","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jid.2017.10.024_bib35","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/j.1365-2133.2004.05984.x","article-title":"The inflammatory response in mild and in severe psoriasis","volume":"150","author":"Rocha-Pereira","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2017.10.024_bib36","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1080\/03009740802448825","article-title":"Rheumatoid arthritis in UK primary care: incidence and prior morbidity","volume":"38","author":"Rodriguez","year":"2009","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.jid.2017.10.024_bib37","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.jhep.2007.01.024","article-title":"Psoriasis patients with diabetes type 2 are at high risk of developing liver fibrosis during methotrexate treatment","volume":"46","author":"Rosenberg","year":"2007","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jid.2017.10.024_bib38","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0190-9622(03)00803-X","article-title":"Methotrexate and psoriasis in the era of new biologic agents","volume":"50","author":"Saporito","year":"2004","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jid.2017.10.024_bib39","first-page":"602","article-title":"Validity of The Health Improvement Network (THIN) for the study of psoriasis","volume":"164","author":"Seminara","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2017.10.024_bib40","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jdermsci.2011.03.002","article-title":"Epidemiology and comorbidities of psoriasis patients in a national database in Taiwan","volume":"63","author":"Tsai","year":"2011","journal-title":"J\u00a0Dermatol Sci"},{"key":"10.1016\/j.jid.2017.10.024_bib41","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.jaad.2013.10.044","article-title":"Psoriasis is independently associated with nonalcoholic fatty liver disease in patients 55 years old or older: results from a population-based study","volume":"70","author":"van der Voort","year":"2014","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jid.2017.10.024_bib42","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2340\/00015555-2161","article-title":"Increased prevalence of advanced liver fibrosis in patients with psoriasis: a cross-sectional analysis from the Rotterdam study","volume":"96","author":"van der Voort","year":"2016","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jid.2017.10.024_bib43","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.ijsu.2014.07.013","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies","volume":"12","author":"von Elm","year":"2014","journal-title":"Int J Surg"},{"key":"10.1016\/j.jid.2017.10.024_bib44","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/art.1780360307","article-title":"Determinants of serious liver disease among patients receiving low-dose methotrexate for rheumatoid arthritis","volume":"36","author":"Walker","year":"1993","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jid.2017.10.024_bib45","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1001\/archinte.162.10.1105","article-title":"Lower risk of thromboembolic cardiovascular events with naproxen among patients with rheumatoid arthritis","volume":"162","author":"Watson","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jid.2017.10.024_bib46","first-page":"1196","article-title":"All-cause mortality and vascular events among patients with rheumatoid arthritis, osteoarthritis, or no arthritis in the UK General Practice Research Database","volume":"30","author":"Watson","year":"2003","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.jid.2017.10.024_bib47","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/0002-9343(91)90667-M","article-title":"Methotrexate and histologic hepatic abnormalities: a meta-analysis","volume":"90","author":"Whiting-O'Keefe","year":"1991","journal-title":"Am J Med"},{"key":"10.1016\/j.jid.2017.10.024_bib48","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1111\/j.1365-2133.2011.10494.x","article-title":"Medical comorbidity associated with psoriasis in adults: a population-based study","volume":"165","author":"Yang","year":"2011","journal-title":"Br J Dermatol"},{"issue":"Suppl 61","key":"10.1016\/j.jid.2017.10.024_bib49","first-page":"S65","article-title":"Long-term safety of methotrexate in the treatment of rheumatoid arthritis","volume":"28","author":"Yazici","year":"2010","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jid.2017.10.024_bib50","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1001\/jamadermatol.2013.5015","article-title":"Psoriasis severity and the prevalence of major medical comorbidity: a population-based study","volume":"149","author":"Yeung","year":"2013","journal-title":"JAMA Dermatology"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X1733097X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X1733097X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T00:24:15Z","timestamp":1603239855000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X1733097X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S0022202X1733097X"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2017.10.024","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk of Incident Liver Disease in Patients with Psoriasis, Psoriatic Arthritis, and Rheumatoid Arthritis: A Population-Based Study","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2017.10.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}